Khosla Rachna 4

What Happened

• Rachna Khosla, Senior Vice President, Business Development at Amgen (AMGN), was awarded equity on 2026-05-05: a grant listed as 500 shares (acquired) and a derivative award of 3,266 units valued at $329.59 each (total ≈ $1,076,441). On 2026-05-06, 79 shares were surrendered/withheld to cover tax withholding obligations, valued at $329.59 each (≈ $26,038).
• The awards are grants (not open-market purchases or sales). The 79-share disposition is a routine tax-withholding event, not a directional sale.

Key Details

• Transaction dates and prices: awards on 2026-05-05; tax-withholding disposition on 2026-05-06 at $329.59/share.
• Reported values: derivative award ≈ $1,076,441; tax withholding ≈ $26,038.
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Footnotes of note:
  • F1: The RSUs were granted under Amgen’s Equity Incentive Plan and vest in four equal annual installments (25% per year) beginning 5/5/2027; vested RSUs convert to common shares 1:1.
  • F2: The awards include 69 Dividend Equivalents (credited to unvested RSUs and paid in shares per vesting).
  • F3: Non-qualified stock options were granted and vest/exercise in four equal annual installments beginning 5/5/2027.
• Filing timeliness: filed 2026-05-07 for transactions on 5/5 and 5/6; no late filing indicated.

Context

• The 79-share disposition was to satisfy tax withholding (common when RSUs vest or when awards are settled) — not an open-market sale signaling a change in view.
• The main takeaway for investors: this is an equity compensation grant to a senior executive (worth roughly $1.08M on grant date) with standard multi-year vesting; purchases or sales that indicate personal conviction were not reported.